Furthermore, HSD11B2 expression differed between grades and molecular subtypes, being most pronounced in low-grade endometrioid tumors (Figure 4A) and in MSI-high and NSMP molecular subtypes (Figure 4B). This evidence concerns the gene HSD11B2 and endometrioid tumor.